Please check your internet connection and try again.
# Hepamerz (L-Ornithine L-Aspartate)
## Overview
Hepamerz is a combination of two amino acids, L-ornithine and L-aspartate. It is believed to work by promoting the detoxification of ammonia in the liver and peripheral tissues.
## Primary Indications
* Treatment of latent and manifest hyperammonemia associated with liver disease (e.g., cirrhosis).
## Adult Dosing
* **Intravenous (IV):** Typically administered as an infusion. Common doses range from **10 grams to 30 grams per day**, divided into 2-3 infusions. Specific regimens vary; often initiated with 5 grams every 8-12 hours, potentially increased based on ammonia levels and patient response.
* **Oral:** Doses typically range from **3 grams to 6 grams three times daily**.
## Pediatric Dosing
* Dosing in pediatric populations is not well-established and should be determined by a specialist. Literature suggests doses between **250 mg/kg/day to 500 mg/kg/day** divided into multiple doses for IV administration in children with urea cycle disorders. Oral dosing is also variable.
## Dose Adjustments
* No specific dose adjustments are typically recommended for renal or hepatic impairment, as the drug is metabolized/excreted by the liver and kidneys. However, close monitoring of ammonia levels is crucial.
## Contraindications
* Severe renal insufficiency.
* Hypersensitivity to L-ornithine or L-aspartate.
## Adverse Effects
* Gastrointestinal disturbances (nausea, vomiting, diarrhea) are most common, particularly with oral administration.
* Rarely: rash, headache, fatigue, dizziness.
## Key Drug Interactions
* No significant drug interactions have been widely reported.
## Monitoring
* Serum ammonia levels are critical for assessing efficacy and guiding dose adjustments.
* Liver function tests.
* Renal function tests.
* Electrolytes.
## Clinical Pearls
* The therapeutic benefit is directly related to the reduction of ammonia levels.
* IV administration is generally preferred for acute hyperammonemic crises due to faster onset of action.
* Oral administration can be used for maintenance therapy or in less severe cases.
***
**Disclaimer:** This information is intended for healthcare professionals. Always consult the official prescribing information and relevant clinical guidelines for complete details and to ensure patient safety. Dosing may vary based on individual patient factors, clinical context, and local protocols.
